Package 71335-2496-3

{"route": ["ORAL"], "spl_id": "6651e74d-5691-474c-819d-950ea238be85", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503"], "spl_set_id": ["350336bf-57b1-4d2f-bf25-956bb6023c07"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-1)", "package_ndc": "71335-2496-1", "marketing_start_date": "20240916"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-2)", "package_ndc": "71335-2496-2", "marketing_start_date": "20240916"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-3)", "package_ndc": "71335-2496-3", "marketing_start_date": "20240916"}, {"sample": false, "description": "45 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-4)", "package_ndc": "71335-2496-4", "marketing_start_date": "20240916"}, {"sample": false, "description": "28 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-5)", "package_ndc": "71335-2496-5", "marketing_start_date": "20240916"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2496-6)", "package_ndc": "71335-2496-6", "marketing_start_date": "20240916"}], "brand_name": "Bupropion hydrochloride", "product_id": "71335-2496_6651e74d-5691-474c-819d-950ea238be85", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-2496", "generic_name": "Bupropion hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA216800", "marketing_category": "ANDA", "marketing_start_date": "20230531", "listing_expiration_date": "20261231"}